INTERNATIONAL PATENT: ESOLATE PHARMACEUTICALS LIMITED FILES APPLICATION FOR "NOVEL ORAL CANNABINOID FORMULATIONS"

GENEVA, May 18 -- ESOLATE PHARMACEUTICALS LIMITED (120 Cockfosters Road, BarnetLondon EN4 0DZ) filed a patent application (PCT/EP2024/081400) for "NOVEL ORAL CANNABINOID FORMULATIONS" on Nov 06, 2024. With publication no. WO/2025/099099, the details related to the patent application was published on May 15, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JACKSON, Hardin (c/o Esolate Pharmaceuticals Limited4145 North Service Road, Suite 200Burlington, Ontario L7L 6A3), MACHIN, Devin (c/o Esolate Pharmaceuticals Limited4145 North Service Road, Suite 200Burlington, Ontario L7L 6A3), OH, Jinhee ...